← Leaderboards
Alvin H Schmaier
Case Western Reserve University
$10,124,403
Attributed
$10,124,403
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,124,403 · 9
By mechanism
R01$7,065,856 · 3
R44$1,484,242 · 1
R21$627,321 · 2
R42$585,575 · 1
P01$348,909 · 1
R13$12,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Keith R. McCrae$18,540,560
Others in their field
Top investigators on “Thrombosis”
- Paul M. Ridker · Brigham And Women'S Hospital$59,264,235
- John H Griffin · Scripps Research Institute$29,245,116
- David J. Pinsky · University Of Michigan At Ann Arbor$29,054,903
- Bruce Furie · Beth Israel Deaconess Medical Center$28,093,838
- Denisa D Wagner · Boston Children'S Hospital$24,247,974
- Satya P. Kunapuli · Temple University$22,403,131
Research focus
ThrombosisInvestigationPhenotypeBlood VesselsLaboratory MouseReactive Oxygen SpeciesEndothelial CellsKininsHuman TissueSignal TransductionIn VivoEventDefectProteinsGene ExpressionBlood CoagulationMouse ModelGene TargetingGenetically Modified AnimalsMyocardial InfarctionResistanceKininogensAortaIn Vitro
Grant awards (31)
Tyrosine Kinases and Thrombosis$407,373
R01 · FY2025 · HL · contact PI
Tyrosine Kinases and Thrombosis$435,887
R01 · FY2024 · HL · contact PI
Tyrosine Kinases and Thrombosis$467,830
R01 · FY2023 · HL · contact PI
Tyrosine Kinases and Thrombosis$540,099
R01 · FY2022 · HL · contact PI
Ponatinib Induces Vascular Events in CML-Mechanisms and Correction$179,067
R21 · FY2020 · CA · contact PI
Ponatinib Induces Vascular Events in CML-Mechanisms and Correction$218,406
R21 · FY2019 · CA · contact PI
KININ2018CLE$12,500
R13 · FY2018 · HL · contact PI
Regulation of Kinin Delivery on HUVEC$369,923
R01 · FY2013 · HL · contact PI
Prolylcarboxypeptidase is a Risk Factor for Cardiovascular Disease$112,098
R21 · FY2013 · HL · contact PI
Regulation of Kinin Delivery on HUVEC$388,575
R01 · FY2012 · HL · contact PI
Prolylcarboxypeptidase is a Risk Factor for Cardiovascular Disease$117,750
R21 · FY2012 · HL · contact PI
Regulation of Kinin Delivery on HUVEC$392,500
R01 · FY2011 · HL · contact PI
Regulation of Kinin Delivery on HUVEC$392,500
R01 · FY2010 · HL · contact PI
REGULATION OF KININ DELIVERY ON HUVEC$366,235
R01 · FY2008 · HL · contact PI
REGULATION OF KININ DELIVERY ON HUVEC$366,235
R01 · FY2007 · HL · contact PI
Thrombostatin-A Thrombin Receptor Inhibitor$606,945
R44 · FY2006 · HL · contact PI
REGULATION OF KININ DELIVERY ON HUVEC$377,173
R01 · FY2006 · HL · contact PI
Thrombostatin-A Thrombin Receptor Inhibitor$877,297
R44 · FY2005 · HL
REGULATION OF KININ DELIVERY ON HUVEC$382,500
R01 · FY2005 · HL
REGULATION OF KININ DELIVERY ON HUVEC$327,657
R01 · FY2004 · HL
REGULATION OF KININ DELIVERY ON HUVEC$318,114
R01 · FY2003 · HL
PLASMA PROTEIN PHENOTYPING OF PROTHROMBOTIC MICE$150,923
R01 · FY2003 · HL
REGULATION OF KININ DELIVERY ON HUVEC$308,848
R01 · FY2002 · HL
PLASMA PROTEIN PHENOTYPING OF PROTHROMBOTIC MICE$150,926
R01 · FY2002 · HL
Thrombostatin In The Folts Model for Coronary Thrombosis$585,575
R42 · FY2001 · HL
REGULATION OF KININ DELIVERY ON HUVEC$312,676
R01 · FY2001 · HL
PLASMA PROTEIN PHENOTYPING OF PROTHROMBOTIC MICE$150,929
R01 · FY2001 · HL
CORE--MOUSE COAGULALTION LABORATORY$135,852
P01 · FY2001 · HL
REGULATION OF KININ DELIVERY ON HUVEC$307,606
R01 · FY2000 · HL
CORE--MOUSE COAGULALTION LABORATORY$213,057
P01 · FY2000 · HL
PLASMA PROTEIN PHENOTYPING OF PROTHROMBOTIC MICE$151,347
R01 · FY2000 · HL